Andy
Retired committee member
Authors
Anouk Verveen, Fabiola Müller, Andrew Lloyd, Rona Moss-Morris, Torbjørn Omland, Brenda Penninx, Ruud P.H. Raijmakers, Marike van der Schaaf, Carolina X. Sandler, Knut Stavem, Simon Wessely, Vegard B.B.Wyller, Pythia Nieuwkerk, Hans Knoop
1. Background
Now that the COVID-19 pandemic has been ongoing for almost two years, increasing attention is directed towards what is being called ‘Long COVID’ or ‘post-acute sequelae SARS-CoV-2 infection’ (PASC). Fatigue is one of the main symptoms of PASC [1]. Prevalence rates of fatigue persisting for months after COVID-19 onset range from 9% to 58% depending on time of follow-up, study population, recruitment method and in-depth evaluation [[2], [3], [4]].
Post-infective fatigue syndrome (PIFS) is defined as persistent, severe fatigue after an infection that cannot be explained by other medical or psychiatric conditions, which has been present for at least six months and significantly affects daily functioning [5]. PIFS is not unique to COVID-19. It has been reported after a diverse spectrum of infectious diseases, including but not limited to Q fever, Lyme borreliosis and SARS-CoV-1, where persistent illness and disability is recognised in 10–35% of adolescents or adults [[6], [7], [8]]. Factors predictive of PIFS include clinical and laboratory features indicative of the severity of the acute infection, and psychological factors such as the cognitive and behavioural responses to the acute illness [6,9]. The question why some patients develop PIFS whereas others do not, remains largely unanswered.
The COVID-19 pandemic provides a unique opportunity to investigate pressing questions with respect to the mechanisms that contribute to developing post-COVID-19 fatigue, thereby potentially helping answering unresolved questions regarding PIFS after other infections. The COVID-19 pandemic offers the opportunity to investigate these questions in large scale prospective studies among patients with known dates of infection onset. As COVID-19 is a worldwide pandemic it provides opportunities to investigate social and cultural factors contributing to PIFS. With these opportunities it is important to think about how to transfer knowledge from COVID-19 to foster our understanding of PIFS more broadly. Conversely, research on post-COVID-19 fatigue may benefit from insights from PIFS obtained in previous research.
Open access, https://www.sciencedirect.com/science/article/pii/S0022399922000113
Anouk Verveen, Fabiola Müller, Andrew Lloyd, Rona Moss-Morris, Torbjørn Omland, Brenda Penninx, Ruud P.H. Raijmakers, Marike van der Schaaf, Carolina X. Sandler, Knut Stavem, Simon Wessely, Vegard B.B.Wyller, Pythia Nieuwkerk, Hans Knoop
1. Background
Now that the COVID-19 pandemic has been ongoing for almost two years, increasing attention is directed towards what is being called ‘Long COVID’ or ‘post-acute sequelae SARS-CoV-2 infection’ (PASC). Fatigue is one of the main symptoms of PASC [1]. Prevalence rates of fatigue persisting for months after COVID-19 onset range from 9% to 58% depending on time of follow-up, study population, recruitment method and in-depth evaluation [[2], [3], [4]].
Post-infective fatigue syndrome (PIFS) is defined as persistent, severe fatigue after an infection that cannot be explained by other medical or psychiatric conditions, which has been present for at least six months and significantly affects daily functioning [5]. PIFS is not unique to COVID-19. It has been reported after a diverse spectrum of infectious diseases, including but not limited to Q fever, Lyme borreliosis and SARS-CoV-1, where persistent illness and disability is recognised in 10–35% of adolescents or adults [[6], [7], [8]]. Factors predictive of PIFS include clinical and laboratory features indicative of the severity of the acute infection, and psychological factors such as the cognitive and behavioural responses to the acute illness [6,9]. The question why some patients develop PIFS whereas others do not, remains largely unanswered.
The COVID-19 pandemic provides a unique opportunity to investigate pressing questions with respect to the mechanisms that contribute to developing post-COVID-19 fatigue, thereby potentially helping answering unresolved questions regarding PIFS after other infections. The COVID-19 pandemic offers the opportunity to investigate these questions in large scale prospective studies among patients with known dates of infection onset. As COVID-19 is a worldwide pandemic it provides opportunities to investigate social and cultural factors contributing to PIFS. With these opportunities it is important to think about how to transfer knowledge from COVID-19 to foster our understanding of PIFS more broadly. Conversely, research on post-COVID-19 fatigue may benefit from insights from PIFS obtained in previous research.
Open access, https://www.sciencedirect.com/science/article/pii/S0022399922000113